Tenon Medical Files 8-K on Shareholder Vote

TL;DR

Tenon Medical had a shareholder vote on July 23rd, filed an 8-K. Big news pending.

AI Summary

Tenon Medical, Inc. filed an 8-K on July 25, 2024, reporting on a matter submitted to a vote of security holders on July 23, 2024. The filing details the company's corporate structure and financial information, including its principal executive offices in Los Gatos, California.

Why It Matters

This filing indicates a significant corporate event involving shareholder approval, which could impact the company's future direction and stock performance.

Risk Assessment

Risk Level: medium — Filings related to shareholder votes can signal significant corporate actions or changes that may introduce uncertainty or opportunity.

Key Numbers

• 001-41364 — SEC File Number (Identifies the company's filing history with the SEC.)
• 45-5574718 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Tenon Medical, Inc. (company) — Registrant
• July 23, 2024 (date) — Date of earliest event reported
• July 25, 2024 (date) — Filing date
• Los Gatos, CA (location) — Principal executive offices location

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar

Filing Documents

• ea0209964-8k_tenon.htm (8-K) — 44KB
• 0001013762-24-001130.txt ( ) — 257KB
• tnon-20240723.xsd (EX-101.SCH) — 4KB
• tnon-20240723_def.xml (EX-101.DEF) — 26KB
• tnon-20240723_lab.xml (EX-101.LAB) — 36KB
• tnon-20240723_pre.xml (EX-101.PRE) — 25KB
• ea0209964-8k_tenon_htm.xml (XML) — 5KB

07 Submission

Item 5.07 Submission of Matters to a Vote of Security Holders. On July 23, 2024, Tenon Medical, Inc., a Delaware corporation (the "Company"), held its virtual 2024 Annual Stockholders Meeting (the "Meeting"). As of the close of business on June 3, 2024, the record date for the determination of stockholders entitled to vote at the Meeting, there were 6,348,000 shares of the Company's common stock, par value $0.001 per share, issued and outstanding, with each share entitled to one vote on each proposal at the Meeting. At the Meeting, the combined holders of 3,639,345 shares of the voting stock entitled to notice of and to vote at the Meeting were represented in person or by proxy, representing approximately 57.33% of the outstanding voting shares, and thereby a quorum pursuant to the Delaware General Corporation Law and the bylaws of the Company was present for the transaction of business at the Meeting. The final results for each of the matters considered at the Meeting were as follows: 1. Election of the seven nominees to the Board of Directors of the Company : Name Votes For Withheld Broker Non-Votes Richard Ferrari 2,401,226 35,492 1,202,627 Steven Foster 2,414,743 21,975 1,202,627 Richard Ginn 2,406,883 29,835 1,202,627 Stephen Hochschuler, MD 2,412,845 23,873 1,202,627 Ivan Howard 2,384,482 52,236 1,202,627 Kristine Jacques 2,416,095 20,623 1,202,627 Robert Weigle 2,383,773 52,945 1,202,627 Each director nominee was elected to serve as a director until the Company's 2025 annual meeting of stockholders, or until such person's successor is duly elected and qualified, or until such person's earlier resignation, death or removal. Due to the fact that directors are elected by a plurality of the votes cast, votes could only be cast in favor of or withheld from the nominees and thus votes against were not applicable. 2. Approval of the terms of (i) our Series B Preferred Stock, (ii) the warrants to

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 25, 2024 Tenon Medical, Inc. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 2

View Full Filing

View this 8-K filing on SEC EDGAR